Table 1 The clinical and pathological characteristics of CRC patients in the training and testing sets.
Type | Total N = 409 | Test n = 122 | Train n = 287 | |
|---|---|---|---|---|
Age | < = 60 | 115 (28.12%) | 27 (22.13%) | 88 (30.66%) |
Age | > 60 | 292 (71.39%) | 95 (77.87%) | 197 (68.64%) |
Age | Unknow | 2 (0.49%) | 0 (0%) | 2 (0.7%) |
Gender | FEMALE | 186 (45.48%) | 57 (46.72%) | 129 (44.95%) |
Gender | MALE | 223 (54.52%) | 65 (53.28%) | 158 (55.05%) |
Stage | Stage I | 72 (17.6%) | 24 (19.67%) | 48 (16.72%) |
Stage | Stage II | 157 (38.39%) | 46 (37.7%) | 111 (38.68%) |
Stage | Stage III | 117 (28.61%) | 43 (35.25%) | 74 (25.78%) |
Stage | Stage IV | 52 (12.71%) | 6 (4.92%) | 46 (16.03%) |
Stage | Unknow | 11 (2.69%) | 3 (2.46%) | 8 (2.79%) |
T | T1 | 11 (2.69%) | 6 (4.92%) | 5 (1.74%) |
T | T2 | 74 (18.09%) | 21 (17.21%) | 53 (18.47%) |
T | T3 | 277 (67.73%) | 80 (65.57%) | 197 (68.64%) |
T | T4 | 46 (11.25%) | 15 (12.3%) | 31 (10.8%) |
T | Unknow | 1 (0.24%) | 0 (0%) | 1 (0.35%) |
M | M0 | 304 (74.33%) | 97 (79.51%) | 207 (72.13%) |
M | M1 | 52 (12.71%) | 6 (4.92%) | 46 (16.03%) |
M | Unknow | 53 (12.96%) | 19 (15.57%) | 34 (11.85%) |
N | N0 | 242 (59.17%) | 72 (59.02%) | 170 (59.23%) |
N | N1 | 95 (23.23%) | 30 (24.59%) | 65 (22.65%) |
N | N2 | 72 (17.6%) | 20 (16.39%) | 52 (18.12%) |
